Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds.

Sleigh JN, Buckingham SD, Esmaeili B, Viswanathan M, Cuppen E, Westlund BM, Sattelle DB.

Hum Mol Genet. 2011 Jan 15;20(2):245-60. doi: 10.1093/hmg/ddq459. Epub 2010 Oct 20.

PMID:
20962036
2.

METT-10, a putative methyltransferase, inhibits germ cell proliferative fate in Caenorhabditis elegans.

Dorsett M, Westlund B, Schedl T.

Genetics. 2009 Sep;183(1):233-47. doi: 10.1534/genetics.109.105270. Epub 2009 Jul 13.

3.

Involvement of c-Abl, p53 and the MAP kinase JNK in the cell death program initiated in A2E-laden ARPE-19 cells by exposure to blue light.

Westlund BS, Cai B, Zhou J, Sparrow JR.

Apoptosis. 2009 Jan;14(1):31-41. doi: 10.1007/s10495-008-0285-7.

4.

Invertebrate and fungal model organisms: emerging platforms for drug discovery.

Stilwell GE, Westlund B.

Expert Opin Drug Discov. 2008 Dec;3(12):1383-95. doi: 10.1517/17460440802528139.

PMID:
23506104
5.

Complement activation by bisretinoid constituents of RPE lipofuscin.

Zhou J, Kim SR, Westlund BS, Sparrow JR.

Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1392-9. doi: 10.1167/iovs.08-2868. Epub 2008 Nov 21.

6.

A new class of anthelmintics effective against drug-resistant nematodes.

Kaminsky R, Ducray P, Jung M, Clover R, Rufener L, Bouvier J, Weber SS, Wenger A, Wieland-Berghausen S, Goebel T, Gauvry N, Pautrat F, Skripsky T, Froelich O, Komoin-Oka C, Westlund B, Sluder A, Mäser P.

Nature. 2008 Mar 13;452(7184):176-80. doi: 10.1038/nature06722.

PMID:
18337814
7.

Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans.

Ved R, Saha S, Westlund B, Perier C, Burnam L, Sluder A, Hoener M, Rodrigues CM, Alfonso A, Steer C, Liu L, Przedborski S, Wolozin B.

J Biol Chem. 2005 Dec 30;280(52):42655-42668. doi: 10.1074/jbc.M505910200. Epub 2005 Oct 19.

8.

Invertebrate disease models in neurotherapeutic discovery.

Westlund B, Stilwell G, Sluder A.

Curr Opin Drug Discov Devel. 2004 Mar;7(2):169-78. Review.

PMID:
15603250
9.
10.

Identification of neuropeptide-like protein gene families in Caenorhabditiselegans and other species.

Nathoo AN, Moeller RA, Westlund BA, Hart AC.

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14000-5.

11.

High-throughput isolation of Caenorhabditis elegans deletion mutants.

Liu LX, Spoerke JM, Mulligan EL, Chen J, Reardon B, Westlund B, Sun L, Abel K, Armstrong B, Hardiman G, King J, McCague L, Basson M, Clover R, Johnson CD.

Genome Res. 1999 Sep;9(9):859-67.

12.

Reverse genetic analysis of Caenorhabditis elegans presenilins reveals redundant but unequal roles for sel-12 and hop-1 in Notch-pathway signaling.

Westlund B, Parry D, Clover R, Basson M, Johnson CD.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2497-502.

13.
15.

Adult male positioning in baboon progressions: order and chaos revisited.

Rhine RJ, Westlund BJ.

Folia Primatol (Basel). 1981;35(2-3):77-116.

PMID:
7262721
16.

Supplemental Content

Loading ...
Support Center